3rd Quarter - Report

BIOMET, INC. for BIOMET, INC.

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H.R. 436 - Protect Medical Innovation Act; FDA 510(k) Reform Proposal; S.17-Medical Device Access and Innovation Act; S. 727, Bill to Amend Internal Revenue Code of 1986

LobbyistCovered position, as disclosed
WILLIAM C KOLTER —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 17 (112th), H.R. 436 (112th), S. 727 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.